<DOC>
	<DOCNO>NCT00793780</DOCNO>
	<brief_summary>The purpose clinical trial find effective low dose oral naltrexone reduce body weight compare placebo woman schizophrenia schizoaffective disorder .</brief_summary>
	<brief_title>Pilot Trial Naltrexone Obesity Women With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Women age 18 70 Meet DSMIV ( Diagnostic Statistical Manual version IV ) criteria schizophrenia schizoaffective disorder base SCID ( Structured Clinical Interview DSMIV ) interview Overweight , define BMI equal great 27 kg/mÂ² continue weight gain past year 2 % previous year total body weight Be stable dose antipsychotic medication ; i.e . least one month dosage change , two month antipsychotic switch ; 5 ) Deemed symptomatically stable clinical staff last two month Meet criterion current alcohol substance dependence , opioid use reason positive urine drug screen opiates A history dementia , mental retardation neurological disorder may interfere study rating Not capable give informed consent participation study Ongoing pregnancy Known sensitivity naltrexone A medical disorder know cause obesity Use sibutramine , topiramate , amphetamine counter weight remedy Impaired liver function ( great 3 time upper limit normal ) Diagnosed polycystic ovary syndrome Currently treat insulin Current use DepoProvera natural/synthetic hormone treatment know cause significant weight gain</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>obesity</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>weight loss</keyword>
</DOC>